“…For example, compared to 25% in the general U.S. adult population, prevalence of current smoking among MM patients is 84% to 94% (Clemmey, Brooner, Chutuape, Kidorf, & Stitzer, 1997;Nahvi, Richter, Li, Modali, & Arnsten, 2006;Richter, Gibson, Ahulwalia, & Schmelzle, 2001). As is the case in the general population, smoking in MM patients is associated with increased morbidity and mortality (Engstrom, Adamsson, Allebeck, & Rydberg, 1991;Hser, McCarthy, & Anglin, 1994). The mortality rate of opioid-dependent smokers, for example, is estimated to be four times greater than that of opioid-dependent nonsmokers (Hser et al).…”